Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
One Biosciences secures €3.3M in non-dilutive public funding from Bpifrance to advance its single-cell precision oncology platform and support clinical translation.
SacramentoBiotechnologyDescription
One Biosciences, a Paris-based techbio startup, received €3.3M in non-dilutive public funding awarded by Bpifrance under the i-Démo 5 project call as part of France 2030 initiative. The grant will finance the CAST project, a four-year clinical translation program in collaboration with Institut Curie. Funds will be used to industrialize the company's molecular profiling platform, validate predictive biomarkers, prepare for CE-IVD regulatory approvals, and scale clinical laboratory infrastructure. One Biosciences develops OneMap™, a single-cell transcriptomics platform designed to guide personalized oncology treatment for Triple-Negative Breast Cancer.
Related People
One Bio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.